managing amr- the case of ghana. martha gyansa-lutterod (ghana)
TRANSCRIPT
Martha Gyansa-Lutterodt Director Pharmaceutical Services
Ministry of Health Chairperson, Ghana Antimicrobial Resistance Alliance
3rd Joint Meeting of the Antimicrobial Resistance and Healthcare-Associated Infections Networks in Stockholm, Sweden on February
12, 2015
Managing Antimicrobial Resistance: the case of Ghana
##
#
#
##
#
##
#
#
#
#
#
##
#
#
#
#
#
#
#
#
#
##
#
# ##
###
#
##
#
#
#
#
#
##
#
#
#
##
#
#
#
##
#
#
#
#
#
#
#
##
#
#
##
#
#
#
#
#
## #
#
####
##
#
#
##
#
#
#
#
##
#
#
#
#
#
#
#
#
#
#
##
#
#
#
#
##
#Y
#Y
#Y
#Y
#Y
#Y
#Y
#Y
#Y
#Y
LAWRALAWRA
TUMU
NADAWLI
WA
SANDEMA
NAVRONGO
BOLGATANGA
BONGO ZEBILLA
GAMBAGA
WALEWALE
BAWKU
TOLON TAMALE
SAVELUGU
GUSHIEGU
YENDI
SABOBA
ZABZUGU
BIMBILA
DAMONGOBOLE
SALAGA
KINTAMPO
ATEBUBU KWAME DANSO
NKORANZATECHIMAN
WENCHI
EJURASUNYANI
DROBO
BEREKUM
DORMAA AHENKRO
BECHEM
KENYASE NO. 1TEPA OFINSOAGONA AKROFOSO
EFFIDUASEMAMPONTENG
MANKRANSOGOASO
KUMASI EJISUNKAWIE
KUNTENASE
KONONGO-ODUMASE
JUASO
BEKWAIMANSO NKWANTA
MAMPONG ASHANTI
OBUASI
NEW EDUBIASE
NEW ABIREM
MPRAESO
BEGORO
KIBIKADE
AKIM ODAASAMANKESE
SUHUM
KOFORIDUA ODUMASE KROBOSOMANYA
ATIMPOKU
AKROPONG AKWAPIM
DODOWANSAWAM
AMASAMAN
ACCRATEMA MUNICIPAL AREA
AGONA SWEDRU
WINNEBAAPAM
SALTPOND
CAPE COASTELMINA
DABOASE
TWIFO PRASOASSIN FOSU
AJUMAKO
BREMAN ASIKUMA
ABURA DUNKWA
HO
DUNKWA-ON-OFIN
TARKWA
SEKONDI/ TAKORADIAGONA NKWANTAAXIM
HALF ASSINI
ASANKRAGUA
SEFWI WIAWSO
JUABESO
ENCHI
BIBIANI
AKATSI DENU
ADA FOAH
SOGAKOPEADIDOME
KPANDU
KADJEBI
JASIKAN
HOHOEDONKORKROM
KETE-KRACHI
NKWANTA
Upper West
Upper East
Northern
Brong Ahafo
Ashanti
Vol taEastern
WesternCent ral Greater Accra
RegionsAshantiBrong AhafoCentralEasternGreater AccraNorthernUpper EastUpper WestVoltaWestern
Water body# District Capital#Y Regional Capital
Ghana boundary
200 0 200 400 KilometersN
EW
S
Ghana Map
Prepared by Alexander Boakye Marful, July 2005
Ghana
Total Population (2012) 25,366,000
Gross National income per capita (PPP international $, 2012) 1,910
Total expenditure on health per capita (Intl $, 2012) 106
Total expenditure on health as % of GDP (2012) 5.2
Life expectancy at birth m/f (years, 2012) 61/64
Probability of dying between 15 and 60 years m/f (per 1000 population, 2012) 263/227
Ghana Facts and figures
Introduction: the need for AMR interventions
Major causes of mortality
Conditions affected directly by AMR
Conditions Not directly affected by AMR 40% 60%
Introduction: Access to essential medicines Availability
Availability of medicines >85% for 65 tracer medicines *
Affordability Social health insurance
reimbursing 548 medicines (13.1% antibiotics)
Out of pocket payments Accessibility: Geographical
distribution of medicines outlets Private Pharmacies >80%
urban Licensed chemical sellers
>80% rural Public health facilities, CHPS
Quality SSFFCs and Storage
conditions
*Office of the Chief Pharmacist 2013 data
Ghana Drug Access Problem Ratio
Quality40%
Accessibility20%
Affordability40%
Quality 40%
Accessibility 20%
Affordability 40%
Policy perspective
The National Drug Policy Standard Treatment Guidelines (STGs) & Essential
Medicines Lists (EMLs) with levels of care National Health Insurance Lists (NHIL) Food and Drugs Authority Register, with classification of
medicines Over the Counter medicines, Pharmacy Medicines, Prescription Only
Medicines
Pharmacy council -Major/common human pathogens considered: E. coli, Klebsiella, Salmonella, Pneumococci, Staphylococcus aureus
-Common antibiotics recommended STGs: Amoxicillin, Erythromycin, Ceftriaxone, Tetracycline, Cefuroxime, Gentamicin, Ampicillin, Ciprofloxacin
Policy assessment: sustaining the gains made by positive interventions on trends in RUM
The National Drug Policy recommends routine monitoring of Rational use of medicines (RUM) The WHO core indicators adopted for use in country, includes
one direct indicator for antibiotic use
Office of the Chief Pharmacist, 1999 to 2013
The indicator trend, aligns with investments in DTC training
56.3
40.5 41.4 43.1 36.4
45.2 40.7
37.6
48.7 49.5 42.0 43.6 43.3 41.4 39.9
15.0
25.0
35.0
45.0
55.0
65.0
75.0
1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013
Percentage of outpatient encounters with an antibiotic prescribed from 1999 to 2013 in Ghana
Ghana AMR initiatives
Other Challenges in the use of Antibiotics
Use of antibiotics in aquaculture Incentives for the use antibiotics in firm farming ‘Tilapia’ fish farming
Use of antibiotics in animal husbandry Need to strengthen rational use of medicines in veterinary
practice (treatment protocols and standards) Veterinary public health service has been engaged on the Ghana
AMR platform
Nascent surveillance system The Surveillance system is nascent that requires standardization
and quality assurance to feed into global actions
The impact of these challenges: The need for efficient stewardship programmes
0.9 0.9 0.9 0.9 1.7 2.6 2.6
5.2 6.1
14.8 24.3
39.1
Deworm DrugFlucloxacillin
MethicillinNivaquine
Co-trimoxazoleAmodiaquineCiprofloxacin
CloxacillinChloroquine
AmoxicillinAmpicillin
ChoramphenicolProportion (%)
Examples of ineffective antibiotics as given by respondents in KABP assessment on CSOs, Non-Health professionals
Medicines users are faced with the implications of AMR on treatment outcomes, cost etc.
Aligns with Resistance to Amp, Chl in Ghana -Ampicillin 76% -Chloramphenicol 75% Newman et al, 2011
The Beginning of AMR program in Ghana
The role of o ‘The race against Resistance’ - Working Group -Centre for Global
Health Development o The Uppsala Summit on ABR in 2010 o Local institutional leadership in a multi-stakeholder approach
The Ghana Ministry of Health (AMR agenda at May 2014 Health Forum in Ghana)
Multi-stakeholder approach (Ghana AMR stakeholder platform) o Partnerships and synergies
Swedish International Development Agency, ReAct Project-Uppsala University),
World Health Organization (WHO)
What is happening in Ghana-highlights
Baseline assessment Situational analysis, stakeholder analysis, Assessment
of knowledge attitudes beliefs and practices of Health professionals and CSOs in health, baseline assessment of resistance
Policy processes. Ghana AMR policy is ready for parliamentary action
Capacity building CSOs in Health Capacity building programs (under ADMER-project)
African Antibiotic Use conference March 18-20 ,2015 Communication
Papers, Websites, Media
Training of Trainers – CSOs in Health
CSO – Region/location No.
GCNH: IDC - Northern 37
AWI - Western 33
HFFG - Central 29 LAPAG - Greater Accra 25 CSHC - Greater Accra 32 TOTAL 156
Some pre-post test results of CSO training
6 2
9
3
12
4
0
5
10
15
20
25
30
35
pre post pre post pre post
Central Northern Western
Pre-Post test response to Bacteria and Virus are the same for 3 regions
No No Answer Yes
0
5
10
15
20
25
30
35
post pre post pre post pre post pre
AccraLapag Central Northern Western
Pre-Post test response to Microbes live in harmony with the environment for 4 CSO
groups
No No answer Yes
Orientation/Sensitization of Key Stakeholders
Over 80 key stakeholders sensitized in western region
About 30 Queen mothers in central
10 municipal health directorate staff
Pharmacist Annual Meeting
AGM of Ward nurses AMR TWG Health Summit
Summary of issues-lessons from Ghana ① The need for broad policy framework
Antimicrobial resistance vrs Antibiotic resistance Key policy areas Community education and Sociocultural change interventions
② Role of Legislative instruments ① Distribution and use
③ Balancing access, excess and equity (inline with distribution of appropriate cadres and level of use)
④ Quality of antimicrobial agents- regulatory mechanisms ⑤ The role of health system issues
Infection Control strategies- Policy review in progress Laboratory capacity and logistics Community actions and participation
Summary of issues-lessons from Ghana
⑥ Need for an expanded monitoring framework RUM indicators (1 indicator for Antibiotic use)
⑦ Alignment and contextualization within existing policies on medicines
Infection control policy National Medicines Policy EML policy
⑧ Linking surveillance data with selection of antibiotics
Reports, Training Manuals, Educational materials
Publications and Papers
3 more manuscripts almost ready
www.ghndp.org/antimicrobialresistance
www.admerproject.org
END Thank you